TrueVision 3D Surgical announces agreement with Lensar, collaboration with Leica Microsystems

Article

TrueVision 3D Surgical and Lensar Inc. recently announced a global co-development and distribution agreement that integrates TrueVision’s TrueGuide system into the Lensar Laser System’s technology suite.

Orlando, FL-TrueVision 3D Surgical and Lensar Inc. recently announced a global co-development and distribution agreement that integrates TrueVision’s TrueGuide system into the Lensar Laser System’s technology suite.  

Lensar’s augmented reality imaging technology rotates around the eye and takes scanning images at multiple angles to locate and identify the relevant ocular surfaces, measuring them, and capturing exact biometric data. This information is then used to create a 3D model of the anterior anatomy to help guide customized treatment and precise laser placement of each laser pulse.

In related news, TrueVision 3D Surgical and Leica Microsystems recently announced that Leica will incorporate key components of TrueVision’s 3D intelligent digital visualization and guidance platform into selected Leica Microsystems surgical products under the Leica brand. In addition to co-marketing the Leica and 3D by TrueVision products, the 2 companies will collaborate on projects that will further integrate their respective optical and digital technologies to improve microsurgery outcomes in ophthalmology and neurosurgery.

Recent Videos
Eye care practitioners reported moderate to high satisfaction with lifitegrast's ability to improve signs of dry eye, according to Melissa Barnett, OD, FAAO, FSLS.
Neda Gioia, OD, CNS, FOWNS, details the positive feedback gained so far from other optometrists that have been prescribing the NutriTears supplement to their dry eye patients.
Damaris Raymondi, OD, FAAO, highlighted the importance of building patient-doctor trust to learn about these practices, which can include non-traditional treatments like chamomile or manuka honey eye drops.
Noreen Shaikh, OD, Magdalena Stec, OD, FAAO, and Brenda Bohnsack, MD, PhD, emphasize that collaboration and communication are key to proper diagnosis and treatment.
Cecilia Koetting, OD, FAAO, DipABO, cited data from a recent student that found that presbyopia treatment with 0.4% pilocarpine led to up to 86% of patients achieving 20/40 or better.
Kerry Giedd, OD, MS, FAAO, was 1 of 20 investigators around the country for a study evaluating the daily disposable contact lens.
According to A. Paul Chous, MA, OD, FAAO, optometrists have an important opportunity to educate patients in their chairs about diabetes.
David Geffen, OD, FAAO, gave a poster presentation titled "Revolutionizing Comfort: Unveiling the Potential of Perfluorohexyloctane Eyedrops for Contact Lens Wearers" at this year's Academy meeting.
Jessica Steen, OD, FAAO, Dipl-ABO, discussed ophthalmic considerations for patients undergoing treatment with antibody drug conjugates for gynecologic cancers at this year's conference.
A. Paul Chous, MA, OD, FAAO, details a presentation on this year's updates on diabetes given at this year's Academy meeting
© 2024 MJH Life Sciences

All rights reserved.